Review Article
Roles of the WHHL Rabbit in Translational Research on Hypercholesterolemia and Cardiovascular Diseases
Table 2
Drug development using WHHL/WHHLMI rabbits.
| | | Lipid-lowering effect | Lipid-lowering effect | | Aorta | Coronary arteries |
| | Cholesterol synthesis inhibitors | | | | | Statins | O | X, O | O | | Squalene synthesis inhibitor | O | O | O | | Anion exchanger | O | O | | | Statins + Anion exchanger | O | O | O | | MTP inhibitor | O | | | | ACAT inhibitor | X, O | X, O | X, O | | Antioxidants | | | | | Probucol | O | O | | | Vitamin E | X | X, O | | | Colony stimulating factor | | | | | MCSF | X, O | O | | | GMCSF | X, O | O | | | Apo E | X, O | O | | | Fibrate | X | | | | Fish oils, ommega-3 fatty acids | X, O | X, O | | | Thiazolidinedione | X | Δ | Δ | | Thiazolidinedione + statin | O | O | O | | Antihypertensive | | | | | ACE inhibitor | X | O | | | AT-II receptor antagonists | X | O | | | Calcium antagonists | X | X | | | Beta-blockers | X | X | | | Gene therapy | O | | |
|
|
O: effective; Δ: partly effective; X: no effect. Modified from Shiomi and Ito [8].
|